Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
Insurer denies Rs 20 lakh life insurance claim over diabetes non-disclosure; woman fights back and wins; here’s whyA Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the St...
22 May, 2026, 11.44 AM IST
Biocon shifts focus to margins, capacity utilisation after expansion phaseBiocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in g...
08 May, 2026, 10.19 PM IST
'Thank God' Kiran Mazumdar Shaw did not become a doctor: When Dr Devi Shetty shared a life lesson from Biocon founder's inspiring journeyA missed medical college admission propelled Kiran Mazumdar-Shaw towards a different path, ultimately leading to the founding of Biocon. Re...
07 May, 2026, 08.10 AM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Health Ministry releases guidance document on Childhood Diabetes at National SummitThe Guidance Document establishes, for the first time, a structured and standardised national framework for the screening, diagnosis, treat...
03 May, 2026, 03.18 PM IST
8 minutes saved today, health destroyed for 50 years: IITian shares shocking truth about modern parenting that harms kidsA Bengaluru-based IIT Kharagpur alumnus, Jagannath Das, has raised concerns about how everyday food habits at home are affecting children’s...
12 Apr, 2026, 10.19 PM IST
With sights on huge gains, Biocon to scale up AI focusBiopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing...
08 Apr, 2026, 12.38 AM IST
Biocon not to rush generic semaglutide to packed India market, says incoming CEO Shreehas TambeBiocon will delay its Indian launch of semaglutide. The company is focusing on international markets for the diabetes and weight-management...
27 Mar, 2026, 10.35 PM IST
This surprising diet helps Type 1 Diabetes patients slash their insulin useA new study suggests a low-fat vegan diet can significantly reduce insulin needs for type 1 diabetes patients. This dietary change may also...
23 Oct, 2025, 01.12 AM IST
Game changer: California launches $11 state brand to slash Diabetes costsCalifornia is set to launch its own low cost insulin under the CalRx beginning from January 1, 2026, representing a major step in the state...
17 Oct, 2025, 11.29 PM IST
Big revolution! Scientists create new smart insulin that responds to changing blood sugar in real timeA new kind of insulin is now in rapid development, which responds according to the spike in blood sugar levels. This new, smart insulin wou...
13 Aug, 2024, 08.55 PM IST
Weekly-once insulin jab may soon come to IndiaA new weekly insulin dosage by Novo Nordisk, Insulin Icodec, is on the brink of approval in India, offering potential relief for those who ...
03 Jul, 2024, 08.20 AM IST
Most of House Republicans in US vote against capping price of insulinThe US House of Representatives has passed a bill popularly known as the Insulin Price Bill that limits insulin costs to $35 per month. The...
01 Apr, 2022, 08.28 PM IST
Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts’ largest formulary in USThe listing is expected to boost Biocon's biosimilar business, as inclusion of Semglee on Express Scripts' NPF will allow pharmacies to sub...
21 Oct, 2021, 10.30 AM IST
Long-acting insulin more effective for type 1 diabetesCompared to intermediate-acting NPH, long-acting insulin improved Hemoglobin A1C levels, a measure of effective blood sugar control over ti...
02 Oct, 2014, 05.56 PM IST
- Wockhardt, Biocon insulin prices to fall by 70%
Indian copycats of French drug maker Sanofi Aventis’ premium insulin formulation, Lantus, will soon become about 70% cheaper with the count...
04 Aug, 2009, 02.59 AM IST